Beauty

Tariffs are expected again under a second Trump Administration and the future of the Americas Partnership for Economic Prosperity is uncertain, says the Personal Care Products Council, which will continue to push for regulatory alignment and lower trade barriers.

E.l.f. Beauty isn’t worried about potential tariffs imposed under the incoming Trump Administration, as it is less reliant on products from China than it was during 2018/2019 tariffs and has a playbook ‘and a number of levers at our disposal’ to mitigate the cost impact.

Whether Democrat Harris or Republican Trump is in White House or which party has majority in either chamber of Congress, the FDA’s conundrum will continue around a regulatory pathway for allowing use of ingredients derived from hemp in supplements.

The European Chemicals Agency’s Forum for Exchange of Information on Enforcement is encouraging cosmetics companies to brush up on the provisions of REACH and a European regulation on persistent organic pollutants after it found 6.4% of nearly 4,500 cosmetic products contain banned hazardous chemicals.

New York-based International Flavors & Fragrances, Inc.’s Scent division is undertaking R&D in natural, synthetic chemistry and biotech molecules, says CEO Erik Fyrwald during a third quarter earnings presentation 6 November.

Houston-based skin care company Drunk Elephant was able to support an Instagram post claim that 17 of its products are ‘safe for kids and teens’ to use, providing an independent assessment of its products based on the European Commission’s Scientific Committee on Consumer Safety (SCCS) standard for testing cosmetics.

Firm’s future, as a separate business nearly 90% owned by Bausch Health, or as a standalone with different ownership or one not controlled by a majority owner, claims high profile in analysts’ comments and predictions. B+L is in the driver’s seat, they say.

The Estee Lauder Companies, Inc.’s Mainland China business weakened ‘substantially’ from a 10% decline in Q4, prompting the firm to pull its fiscal year 2025 sales outlook and forecasting reported and organic net sales in the fiscal second quarter will fall 6%-8%.

Xytogen Biotech’s Factorfive stem cell-based skin care delivers benefits that are greater than the company claims, says founder and CEO John Aylworth. Available mostly through clinicians’ offices, the formulas are based on a proprietary process that triggers stem cells to send out growth factor signals, which are captured in a ‘conditioned media’ and used as the basis for products.

Bayer adds dry eye treatment to its Bepanthen skin care range; Stada launches special edition Elotrans supplement for Eintracht Frankfurt fans; Hermes offers chewable magnesium supplement; and Klosterfrau introduces Oyono Night extension to help troubled sleepers maintain their immunity.

After launching Retaine MGD Advanced, OcuSoft says a release by Bruder Healthcare referenced Retaine MGD trademark and statements from a previous OcuSoft announcement about the original product attributed to an optometrist. B+L, Rohto brand and homeopathic firm Relief Products also make US OTC eye care space moves.

Perelel acquiring Loom online platform providing reproductive health, sexual wellness and parenting education. First direct-to-consumer product for Curive Healthcare’s Plum brand formulated for vaginal area dryness.